In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others
Avoid any peptide that is not FDA-approved or cannot be legally compounded under current FDA policy
Glucose addiction in cancer therapy: Advances and drawbacks
After co-incubation with degenerative NP extract solution for 4 days, MBC nanozyme maintained the structural integrity, and there was no significant detachment of the membrane coating from MBC
Our dual-peptide approach combines the collagen-boosting power of GHK-Cu with the cellular rejuvenation benefits of NAD+, creating a comprehensive anti-aging strategy that addresses multiple pathways of skin aging simultaneously